Similar Articles
901 Immunohistochemistry panel segregates molecular types of hepatocellular carcinoma in Brazilian autopsy cases
902 Clinical analysis of patients with hepatocellular carcinoma recurrence after living-donor liver transplantation
903 Relationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinoma
904 Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy
905 Liver transplantation for hepatocellular carcinoma in Ireland: Pre-operative alpha-fetoprotein predicts tumour recurrence in a 14-year single-centre national experience
906 Proposal of new expanded selection criteria using total tumor size and 18F-fluorodeoxyglucose - positron emission tomography/computed tomography for living donor liver transplantation in patients with hepatocellular carcinoma: The National Cancer Center Korea criteria
907 Adjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients
908 Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma
909 Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatments
910 miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA